Correlation Between SeqLL and BioAffinity Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both SeqLL and BioAffinity Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SeqLL and BioAffinity Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SeqLL Inc and bioAffinity Technologies Warrant, you can compare the effects of market volatilities on SeqLL and BioAffinity Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SeqLL with a short position of BioAffinity Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of SeqLL and BioAffinity Technologies.

Diversification Opportunities for SeqLL and BioAffinity Technologies

SeqLLBioAffinityDiversified AwaySeqLLBioAffinityDiversified Away100%
0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between SeqLL and BioAffinity is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding SeqLL Inc and bioAffinity Technologies Warra in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioAffinity Technologies and SeqLL is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SeqLL Inc are associated (or correlated) with BioAffinity Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioAffinity Technologies has no effect on the direction of SeqLL i.e., SeqLL and BioAffinity Technologies go up and down completely randomly.

Pair Corralation between SeqLL and BioAffinity Technologies

If you would invest  29.00  in bioAffinity Technologies Warrant on January 18, 2025 and sell it today you would lose (2.00) from holding bioAffinity Technologies Warrant or give up 6.9% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

SeqLL Inc  vs.  bioAffinity Technologies Warra

 Performance 
JavaScript chart by amCharts 3.21.15FebMarApr -60-40-200204060
JavaScript chart by amCharts 3.21.15SQL BIAFW
       Timeline  
SeqLL Inc 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days SeqLL Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, SeqLL is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors.
BioAffinity Technologies 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in bioAffinity Technologies Warrant are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile technical and fundamental indicators, BioAffinity Technologies showed solid returns over the last few months and may actually be approaching a breakup point.
JavaScript chart by amCharts 3.21.15JanFebMarAprFebMarApr0.20.30.40.50.60.70.8

SeqLL and BioAffinity Technologies Volatility Contrast

   Predicted Return Density   
JavaScript chart by amCharts 3.21.15 0.00010.00020.00030.00040.00050.0006
JavaScript chart by amCharts 3.21.15SQL BIAFW
       Returns  

Pair Trading with SeqLL and BioAffinity Technologies

The main advantage of trading using opposite SeqLL and BioAffinity Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SeqLL position performs unexpectedly, BioAffinity Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioAffinity Technologies will offset losses from the drop in BioAffinity Technologies' long position.
The idea behind SeqLL Inc and bioAffinity Technologies Warrant pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges